BENCHMARKS
within autosomal genes are unavailable for assay validation. However, male samples are equivalent to a heterozygous deletion in female samples. Consequently, female samples with heterozygous deletions of an X chromosomal segment are comparable to normal male samples.
RD-PCR was also tested in a prospective study in hemophilia A families to detect heterozygous deletions in X chromosomal segments. RD-PCR assays were designed for exons 6 and 7 of the factor VIII gene. Eight females from two hemophilia A fam alidation of new assays; (iv) utilization of a generic endogenous internal dosage control to eliminate preparation and manipulation errors; (v) detection of gene dosage over a wide dynamic range (3); (vi) tolerance toward genomic DNA of variable quality (J. Shi, Q. Liu, V.Q. Nguyen, and S.S. Sommer, submitted); and (vii) uniform and unbiased performance across regions of variable sequence context and GC content.
The large-scale expression and purification of recombinant proteins needed for structural studies is time-consuming and expensive, especially when costly reagents, such as selenomethionine (SeMet) or 15 N/ 13 C-labeled nuclear magnetic resonance (NMR) medium, are required. Small-scale screens are being developed to identify which targets express and are soluble prior to large-scale expression (1) (2) (3) (4) (5) (6) (7) . Although these screens are designed for a 96-sample, small-scale format, none adequately predicts the reliable expression behavior with scaled-up milliliter and liter fermentations, which has been a challenge for researchers in the field.
We have adapted a low-cost, highvelocity incubating Glas-Col Vertiga shaker (Glas-Col, LLC, Terre Haute, IN, USA; Figure 1A ) to develop an efficient, high-throughput Escherichia coli microliter-scale expression screening protocol that accurately predicts protein behavior expressed in largescale (milliliter and liter) fermentation conditions. The apparatus shakes cultures in three dimensions at speeds of up to 1000 rpm, allowing smallscale (approximately 500 μL) cultures grown in 2-mL 96-deep-well blocks to achieve absorbances (A 600 ) as high as 10-20. This generates sufficient material for the analysis of expression, solubility, and binding to affinity purification matrices. Moreover, this screening strategy has also been used to identify clones that express and are soluble under SeMet (8) or 15 N/ 13 C-labeled expression conditions that are necessary for the production of labeled recombinant proteins for direct structural analysis. The Glas-Col Vertiga shaker can be used to screen for soluble expression clones under native, SeMet, and 15 N/ 13 C-labeled expression conditions.
Microscale expression using the Glas-Col Vertiga shaker is carried out as follows. First, overnight cultures are prepared with 250 μL sterile 2xyt media containing antibiotic (0.3 mM ampicillin) in sterile 2-mL, 96-deep-well, round-bottom blocks (USA Scientific, Ocala, FL, USA). Each well is then inoculated with 1 μL glycerol stocks of expression clones (also stored in a 96-well format) using a multichannel pipet. Once sealed with a sterile, porous plate cover (USA Scientific), the blocks are placed in the Glas-Col Vertiga shaker, and cultures are grown overnight at 37°C, shaking at 550 rpm.
Expression under native conditions is carried out using 500 μL sterile Terrific Broth (TB or 2× TB) media prepared with 100 mM MOPS, pH 7.4, and antibiotic, while expression under SeMet conditions is carried out using sterile complete media with 1 μg/mL FeSO 4 , 0.8 mM SeMet, and antibiotic. Blocks containing the overnight cultures are then centrifuged at 5000× g to pellet the E. coli cells, the supernatants are discarded, and the pellets are resuspended in 100 μL fresh media (TB or SeMet, as appropriate). The freshly prepared expression blocks are then inoculated with 25 μL of the resuspended overnight culture. After sealing each expression block with a porous plate cover, blocks are placed in the GlasCol Vertiga shaker and grown at 900 rpm and 37°C. When the culture A 600 reaches approximately 3 (about 1.5 h following inoculation at 37°C; spectrophotometer wavelength, 600 nm), expression is induced [final concentration of 0.2% (w/v) L-arabinose (Sigma, St. Louis, MO, USA)] and cultures are allowed to shake at 900 rpm and 37°C for an additional 4-5 h. The final average culture A 600 is usually between 10 and 20. Blocks are then centrifuged at 5000× g for 10 min to pellet the cells, and the supernatants are discarded. Blocks with pelleted cells are then analyzed for expression or sealed with a rubber plate seal and stored at -80°C for future analysis. In addition to the L-arabinose expression system (pBAD vector; Invitrogen, Carlsbad, CA, USA), similar microliter-scale and milliliter/liter experiments have also been carried out with the T7 expression system (pET vectors; Novagen, Madison, WI, USA).
Expression and solubility are evaluated using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis (His-tag antibodies). First, frozen bacterial cell pellets are placed at room temperature and allowed to thaw slightly. Cells are then thoroughly resuspended in 100 μL of MP lysis buffer A [50 mM Tris, pH 7.5, 50 mM sucrose, 1 mM EDTA, 0.25 mM tris-(2-carboxyethyl) phosphine hydrochloride (TCEP)] with 1.0 mg/mL lysozyme and 0.25 μL/mL Benzonase ® (Novagen). After incubating at room temperature for 15 min, 100 μL of MP lysis buffer B (10 mM Tris, pH 7.5, 50 mM KCl, 10 mM MgCl 2 , 1 mM EDTA, 0.25 mM TCEP) are added to each well and incubated for an additional 15 min. After mixing, 10 μL samples of the lysate from each well are removed and added to the SDS-PAGE sample buffer. These samples represent the "total lysate" fractions. Samples are then centrifuged at 6100× g for 15 min to pellet cell debris. Following centrifugation, 20 μL of the supernatant are removed for SDS-PAGE analysis. These samples represent the "soluble" fractions.
If desired, the soluble fraction is then purified using immobilized metalaffinity chromatography (IMAC). A 400-μL, 0.45-μm filter-containing 96-well microplate is used for the load, wash, and elution steps, and a 450-μL 96-well plate is placed underneath the filter plate to collect the flow through. One hundred microliters of a 50% slurry of Co 2+ -charged metal-affinity resin (TALON™ Superflow; BD Biosciences Clontech, Palo Alto, CA, USA) are added to each well of the filter plate and equilibrated with 300 μL of equilibration buffer (1:1 mixture of MP lysis buffers A and B). Equilibration buffer is removed by centrifugation at 300× g for 1 min. Clarified lysate supernatants are then added to each well and gently mixed by slowly pipetting up and down for 10 repetitions. The resin is allowed to settle to the bottom of each well and is then centrifuged as before, with new collection plates underneath to collect soluble lysate flowthrough fractions. The resin is then washed once with MP wash buffer (25 mM Tris, pH 7.8, 150 mM NaCl, 5 mM imidazole, 0.25 mM TCEP) and centrifuged as before, saving the flow-through fractions in a third plate. The bound proteins are eluted from the IMAC resin using MP elution buffer (25 mM Tris, pH 7.8, 150 mM NaCl, 150 mM imidazole, 0.25 mM TCEP). The resin is slowly resuspended with 50 μL of elution buffer, after which the resin beads are allowed to settle for 10 min. The filter plates are then centrifuged a final time, using a new 450-μL 96-well plate to collect the eluate. Purified proteins can be used for additional analytical studies, such as mass spectrometry or size exclusion chromatography, as desired. A complete analysis of recombinant protein expression is performed by running 4%-20% SDS-PAGE gels of the total lysate, soluble, flow-through (unbound), and eluate fractions. 
For comparison to larger-scale fermentation behavior, 34 proteins were expressed using the microliter-scale expression protocol under native conditions and expressed again using the Genomics Institute of the Novartis Research Foundation (GNF; San Diego, CA, USA) 96-well milliliter fermenter ( Figure 1B ). This experiment was carried out in duplicate. Targets expressed in the GNF 96-well fermenter were purified as outlined by Lesley, et al. (9) , with purity and yield determined by SDS-PAGE. Most samples were further analyzed using Western blot analysis with an anti-His antibody (Sigma) using standard protocols. Of the 34 proteins tested, 32 consistently expressed (or did not express) in both microliter and larger-scale volumes, illustrating a high level of scalability and correlation in BENCHMARKS the expression levels of soluble protein between the Vertiga screening trials and large-scale growth conditions (Table 1) . In contrast, without the Vertiga shaker, the correlation between microliter-and milliliter-(and liter) scale expression is much lower (data not shown). The two proteins that behaved differently between micro-and macro-expression, BH0832 (GenBank ® accession no. 10173447) and AGR_L_2357p (accession no. 15159665), did so in only one of the two experiments; in the second, the micro-and macro-expression behavior was identical for both proteins (Table  1) . Finally, eukaryotic proteins from Saccharomyces cerevisiae and viral proteins from the Severe Acute Respiratory Syndrome (SARS) virus have also been successfully micro-expressed in E. coli using this device. These results demonstrate that the microliter-scale expression protocol developed using the Vertiga vertical shaker can be used to accurately identify proteins that will express solubly in larger-scale fermentation conditions. Moreover, the results from these screens can be used to assess the solubility and expected protein yield for each potential protein target for both native and labeled E. coli recombinant expression. Future developments include using material directly from microliter-scale expression for biophysical analysis, including nanovolume crystallization (10) and other biophysical techniques currently being miniaturized.
